Results for

""ATP Binding Cassette Transporter, Subfamily G, Member 2""[mesh_terms]

The Role of the Intestine in the Development of Hyperuricemia.

Hui Yin, Na Liu, Jie Chen

Frontiers in immunology 2022;13():845684

Breast cancer resistance protein (BCRP/ABCG2).

Petr Pavek, Frantisek Staud

The international journal of biochemistry & cell biology 2005;37(4):720-5

Breast Cancer Resistance Protein: A Potential Therapeutic Target for Cancer.

Sonali Mehendale-Munj, Shivangi Sawant

Current drug targets 2021;22(4):420-428

Effect of Roxadustat on the Pharmacokinetics of Simvastatin, Rosuvastatin, and Atorvastatin in Healthy Subjects: Results From 3 Phase 1, Open-Label, 1-Sequence, Crossover Studies.

Virginie Kerbusch, Martin den Adel, Dorien Groenendaal-van de Meent, Jan van Dijk, Tomohisa Shibata, Marloes Schaddelee, Kota Kato

Clinical pharmacology in drug development 2022;11(4):486-501

A close examination of BCRP's role in lactation and methods for predicting drug distribution into milk.

Lu Gaohua, Brian J Schmidt, Caroline Sychterz, Aleksandra Galetin, Amin Rostami-Hodjegan, Hong Shen, Michael Sinz, Yueping Zhang

CPT: pharmacometrics & systems pharmacology 2024;13(11):1856-1869

Low-dose daily folic acid (400 μg) supplementation does not affect regulation of folate transporters found present throughout the terminal ileum and colon of humans: a randomized clinical trial.

Deborah L O'Connor, Young-In Kim, Reina Bendayan, Norman Marcon, Susanne Aufreiter, George Biouss, Nancy Basset, Md Tozammel Hoque, Siya Khanna, Colleen C Farrell, Aneta Plaga, Ishba Syed

The American journal of clinical nutrition 2024;119(3):809-820

Solvation Free Energies of Drug-like Molecules via Fast Growth in an Explicit Solvent: Assessment of the AM1-BCC, RESP/HF/6-31G*, RESP-QM/MM, and ABCG2 Fixed-Charge Approaches.

Piero Procacci, Marco Pagliai, Marina Macchiagodena, Yiqi Geng, Matteo Orlandi

Journal of chemical theory and computation 2025;21(16):7977-7990

Inhibition and stimulation of the human breast cancer resistance protein as in vitro predictor of drug-drug interactions of drugs of abuse.

Lea Wagmann, Markus R Meyer, Hans H Maurer

Archives of toxicology 2019;92(9):2875-2884

A Pilot Study To Assess the Suitability of Riboflavin As a Surrogate Marker of Breast Cancer Resistance Protein in Healthy Participants.

Weiqi Chen, Yongjun Xue, Yueping Zhang, Kofi Mensah, Andrew J Paris, Nian Tong, Runlan Huo, Min Chen, Linna Wang, Hong Shen, Michael Sinz, Wenying Li

The Journal of pharmacology and experimental therapeutics 2024;390(2):162-173

Breast cancer resistance protein: molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics.

Yoshikazu Sugimoto, Satomi Tsukahara, Etsuko Ishikawa, Junko Mitsuhashi

Cancer science 2005;96(8):457-65

The role of catechin in electroporation of pancreatic cancer cells - Effects on pore formation and multidrug resistance proteins.

Julita Kulbacka, Mounir Tarek, Jolanta Saczko, Dagmara Baczyńska, Wojciech Szlasa, Olga Michel

Bioelectrochemistry (Amsterdam, Netherlands) 2022;147():108199

Functional SNPs of the breast cancer resistance protein-therapeutic effects and inhibitor development.

Kae Yanase, Satomi Tsukahara, Junko Mitsuhashi, Yoshikazu Sugimoto

Cancer letters 2006;234(1):73-80

The frequency of rs2231142 in among Native Hawaiian and Pacific Islander subgroups: implications for personalized rosuvastatin dosing.

Ola AlAzzeh, Youssef M Roman

Pharmacogenomics 2023;24(3):173-182

The frequency of rs2231142 in among Asian subgroups: implications for personalized rosuvastatin dosing.

Youssef M Roman, Khalifa Alrajeh

Pharmacogenomics 2023;24(1):15-26